Rezolute (RZLT) Other Non-Current Liabilities (2014 - 2026)
Rezolute's Other Non-Current Liabilities came in at $468,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from $468,000 a year earlier and down 3.1% from the prior quarter.
Rezolute (RZLT) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
Going back to fiscal Q4 2014, Rezolute's Other Non-Current Liabilities data covers 44 quarters.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of 3.9% (FY2021 to FY2026).
- Going back by fiscal year, Other Non-Current Liabilities was $468,000 in FY2025 (unchanged), $468,000 in FY2024 (+13.6%), $412,000 in FY2023 (+1.2%) and $407,000 in FY2022 (+5.2%).
- The five-year range for quarterly Other Non-Current Liabilities is $371,000 (fiscal Q1 2022) to $483,000 (fiscal Q3 2026).
- Year-over-year, Other Non-Current Liabilities increased in four of the last eight quarters, with growth averaging 3.7%.
- Across the past five years, year-over-year growth in Other Non-Current Liabilities ran from 0.0% in fiscal Q4 2025 to 13.6% in fiscal Q4 2024.
- Business Quant data shows RZLT's Other Non-Current Liabilities at $483,000 (Q3 2026), $483,000 (Q2 2026) and $483,000 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Rezolute | 399.12 Mn | 399.12 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 468,000.00 |
| Mar 31, 2026 | 483,000.00 |
| Dec 31, 2025 | 483,000.00 |
| Sep 30, 2025 | 483,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Mar 31, 2025 | 483,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | 483,000.00 |
| Jun 30, 2024 | 468,000.00 |
| Mar 31, 2024 | 453,000.00 |
| Dec 31, 2023 | 439,000.00 |
| Sep 30, 2023 | 426,000.00 |
| Jun 30, 2023 | 412,000.00 |
| Mar 31, 2023 | 447,000.00 |
| Dec 31, 2022 | 434,000.00 |
| Sep 30, 2022 | 420,000.00 |
| Jun 30, 2022 | 407,000.00 |
| Mar 31, 2022 | 395,000.00 |
| Dec 31, 2021 | 383,000.00 |
| Sep 30, 2021 | 371,000.00 |
Rezolute Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RZLT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "RZLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RZLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();